Delhi, India
In an important medical insight into advanced neurological treatments, Dr P Sarat Chandra explained the role of Deep Brain Stimulation (DBS) in treating Parkinson’s disease, while also raising concern over the increasing number of cases among younger individuals.
Speaking in Delhi, Dr P Sarat Chandra described Deep Brain Stimulation as a surgical therapy used in patients where medications are no longer effective. He said that Parkinson’s patients often experience fluctuations in symptoms over time, which become difficult to manage through medicines alone.
He explained that DBS helps reduce these fluctuations and provides continuous symptom control, offering significant relief to patients.
Unlike conventional medication, which requires strict and regular intake, DBS works through an implanted device that delivers electrical stimulation to specific parts of the brain. According to Dr Chandra, the system operates automatically and requires only periodic monitoring and adjustments, making it more convenient for patients.
He emphasized that DBS offers a continuous and automated treatment approach, reducing dependence on frequent medication schedules.
Dr Chandra also highlighted a concerning trend regarding Parkinson’s disease. Traditionally considered a condition affecting older adults, typically those above 55 to 65 years, the disease is now increasingly being diagnosed in younger individuals.
He noted that cases are now being reported in people in their 30s and 40s, and in some instances, even as young as 25 years, indicating a shift in disease patterns.
On the cost aspect, Dr Chandra said that while the surgical procedure itself is relatively affordable, the overall cost of DBS treatment is high due to the price of the implanted device. He stated that the surgical cost is around ₹10,000, but the DBS device can range from approximately ₹8 to ₹9 lakh for basic models, and up to ₹21 to ₹23 lakh for advanced systems.
He pointed out that the high cost makes DBS inaccessible for many patients, especially those from economically weaker backgrounds.
For patients who cannot afford DBS, Dr Chandra said that alternative surgical procedures such as pallidotomy are offered. While not as advanced as DBS, these procedures still provide relief and are more affordable.
He emphasized that efforts are made to ensure that even economically disadvantaged patients receive appropriate treatment options.
The insights shared by Dr Chandra underline both the advancements in neurological treatment and the challenges related to accessibility and affordability. As Parkinson’s cases continue to rise, especially among younger populations, the need for awareness, early diagnosis, and accessible treatment becomes increasingly important.
The discussion highlights the dual challenge of medical progress and affordability, as healthcare systems work to make advanced treatments like DBS more accessible to all sections of society.
